FDA warns of cybersecurity risk with certain Medtronic insulin pumps
(Reuters) -The U.S. Meals and Drug Administration on Tuesday warned that sure sorts of insulin pump programs manufactured by Medtronic have been susceptible to cyberattacks and that hackers might probably hamper insulin supply by accessing the system.
The company issued a cybersecurity threat alert for the Medtronic MiniMed 600 Sequence insulin pump system, which has a number of elements together with an insulin pump and a blood glucose meter that talk wirelessly.
The FDA stated it was attainable for an unauthorized individual to realize entry to a pump whereas it was pairing with different system elements, however to date, it was not conscious of any reviews associated to this cybersecurity vulnerability.
The insulin pumps are offered via Medtronic’s diabetes section, which introduced in $2.41 billion in gross sales in 2021 and accounted for 8% of the corporate’s complete income.
Medtronic additionally warned customers in regards to the dangers and made suggestions together with asking them to completely flip off the “Distant Bolus” function on the pump, not share system’s serial quantity with unauthorized personnel or conduct any connection linking of gadgets in a public place.
The corporate stated hackers, nevertheless, can’t achieve entry to the system via web.
The FDA stated it was working with Medtronic to determine, talk and stop adversarial occasions associated to this threat.
(Reporting by Mrinalika Roy in Bengaluru; Modifying by Shinjini Ganguli)
